New Research Facility to Advance Genomics SeqOnce Biosciences, Inc., a genomics company creating new tools to detect and analyze human disease, is thrilled to announce it has officially completed their move into a new facility
Next Generation Sequencing (NGS) library construction is a workflow bottleneck. The processes of library construction for DNA and RNA sequencing are complex, error prone, costly, and in general are me consuming. Current commercial products offer multistep, multi-hour sample processing that can
Next-generation sequencing is, by definition, “massively parallel.” While the first 454/Curagen GS20 systems yielded a million reads per run, the latest sequencing platforms from Illumina, (NovaSeq 6000 running their highest-capacity S4 flowcell), yields 10,000X the
SeqOnce is a company founded upon the idea that steps involved in Next Generation Sequencing (NGS) need to be both streamlined and simplified. Having developed and launched the first product, RhinoSeq, NGS library preparation time
Current next Generation Sequencing (NGS) library construction is a bottleneck in the sequencing workflow. The processes of library construction for DNA and RNA sequencing are complex, error prone, costly, and time consuming. Current commercial products
